Moreover, CKI also targets angiogenesis and tumour microenvironment regulating pathways through VEGFA/VEGFR2 and cytokine signalling (B cell receptor, T cell receptor and FC-epsilon signalling) respectively (Supplementary Table 5), which is consistent with a previous finding [62]. The gene discussed is CHKA; the disease is neoplasm.